Back to Top Skip to main content Skip to sub-navigation

DoD closing in on COVID-19 convalescent plasma collection goal

Technician wearing a mask, looking at different blood products The apheresis process separates whole blood into parts, including yellow plasma as seen in the left bag. Doctors are using COVID-19 convalescent plasma to treat critically ill patients with COVID-19. (Photo by Eric Pilgrim)

Recommended Content:

Coronavirus | Convalescent Plasma Collection Program | COVID-19 Vaccine Toolkit | Armed Services Blood Program

The COVID-19 Convalescent Plasma (CCP) Collection Program is a Department of Defense effort to obtain 10,000 units CCP with emphasis on blood donations by members of the military community who have recovered from the disease. CCP will be given to critically ill patients, and to support the development of an effective treatment against the disease. Potential donors should visit the Armed Services Blood Program website to find a complete list of available collection centers.

In just three months, the Department of Defense passed the 65% mark toward meeting its goal of obtaining 10,000 units of COVID-19 convalescent plasma, or CCP, by Sept. 30.

The CCP campaign began in early June to collect plasma from recovered COVID-19 patients to support the development of potential therapies against the highly infectious respiratory virus.

CCP is the liquid part of blood collected from patients who have recovered from a COVID-19 infection. The Food and Drug Administration recently issued Emergency Use Authorization for CCP, authorizing its administration by health care providers, as appropriate, to treat suspected or laboratory-confirmed COVID-19 hospitalized patients.

“Even as we have passed the midpoint, we’ve still got a long way to go to reach our goal. We need all of our beneficiaries who have recovered from COVID-19 to consider donating their convalescent plasma,” said Army Col. Audra Taylor, Armed Services Blood Program division chief.

The ASBP is collecting CCP at nearly all of its donor centers through either whole blood donation or a donation of plasma only. “The most efficient way to collect convalescent plasma is through a process called apheresis. This process takes approximately two hours total time from prescreening to post-donation. During collection, it separates the plasma, or liquid part of the blood, from the red blood cells which are then returned to the donor’s body,” said Army Col. Jason Corley, director, Army Blood Program. A donor can give whole blood donations about every two months, while a donor can give plasma donations more frequently.

Potential donors who have recovered from COVID-19 must be symptom-free for at least 14 days. They should call the ASBP before donating to set up an appointment and ensure they meet eligibility requirements, which include evidence of COVID-19 documented by a laboratory test.

ASBP blood donor centers collecting CCP through apheresis and whole blood donations are located at:

  • Fort Benning: Sullivan Memorial Blood Center
  • Fort Bliss Blood Donor Center
  • Fort Bragg Blood Donor Center
  • Fort Gordon: Kendrick Memorial Blood Center
  • Fort Hood: Robertson Blood Center
  • Fort Leonard Wood Blood Donor Center
  • Joint Base Lewis-McChord: Armed Services Blood Bank Center-Pacific Northwest
  • Joint Base San Antonio-Fort Sam Houston: Akeroyd Blood Donor Center
  • Joint Base San Antonio-Lackland Blood Donor Center
  • Keesler Air Force Base Blood Donor Center
  • Landstuhl Regional Medical Center: Armed Services Blood Bank Center-Europe
  • Naval Hospital Guam Blood Donor Center
  • Naval Medical Center Camp Lejeune Blood Donor Center**
  • Naval Medical Center Portsmouth Blood Donor Center
  • Naval Medical Center San Diego Blood Donor Center
  • Naval Station Great Lakes: Blood Donor Processing Division
  • Tripler Army Medical Center Blood Donor Center
  • U.S. Pacific Command Armed Services Blood Bank Center*
  • Walter Reed National Military Medical Center: Blood Services
  • Wright-Patterson Blood Donor Center*

*ASBP blood donor centers collecting CCP only via whole blood donations
**ASBP blood donor centers collecting CCP only via apheresis

Anyone who wishes to donate whole blood can visit the ASBP website to find upcoming blood drives or call their local blood donor center.

“It's easy to make a donation appointment,” said Navy Lt. Cmdr. Colleen Cordrick, director of the Navy Blood Program. “Go to militarydonor.com, type in your city, state, or zip code, and a list of available locations and drives will appear. Once you've signed up, please try your best to keep the appointment! Unfortunately, we are seeing a larger rate of no-shows, putting an additional strain on the system.”

She added that every missed appointment equates to two missed opportunities to collect plasma—one from the person who didn't show up, and another from the person who could've made that appointment time. “If you can’t make it,” said Cordrick, “please let the donor center know as soon as possible. We look forward to making your experience as safe and comfortable as possible.”

Taylor expressed confidence that active duty service members, retirees, and military health beneficiaries are up to the DoD collection challenge. “If you have recovered from COVID-19, please make your appointment today to help give others a fighting chance and combat COVID,” she said.

You also may be interested in...

DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

DHA-AI 3020-01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (b) and in accordance with the guidance of References (c) through (z3), establishes the Defense Health Agency's (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic. This DHA-AI also provides a preventive plan to monitor and assess for the appearance of new cases and implement those processes that will prevent them from impacting the workforce. The processes describe herein are intended to offer an actionable plan for the workforce to re-enter DHA Administrative Offices. See Appendix 1 for a summary of the DHA Administrative Office Reopening Plan. The plan uses the Force Health Protection Guidance and Health Protection Conditions (HPCON), in accordance with Reference (d), to ensure protection for the workforce, including the most vulnerable-to-serious complications from the virus while enabling DHA Administrative Offices to continue its mission. See Appendix 2 for the conceptual HPCON framework.

  • Identification #: 3020-01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA AI 3020.01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 (COVID-19) Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.

  • Identification #: DHA AI 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

Guidance Regarding Zika Dengue and Chikungunya Viruses

Policy

This guidance contains information about the potential for transfusion-transmitted Zika infection; recommends facilitating donor self-deferral of 28 days after travel to Mexico, the Caribbean, Central America and South America.

DoD Directive 6000.12E: Health Service Support

Policy

This directive designates the Secretary of the Army as the DoD Executive Agent for the Armed Services Blood Program Office (ASBPO) (Reference (h)), who exercises this authority through the Surgeon General of the Army, in accordance with DoDD 5101.1 (Reference (d)).

DoD Instruction 6480.04: Armed Services Blood Program Operational Procedures

Policy

This instruction assign responsibilities, and prescribe procedures to carry out the responsibilities of the Armed Services Blood Program (ASBP) during peacetime, contingency, and wartime operations.

Showing results 1 - 13 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.